Explore the vast range of titles available.

Analysis of circulating tumour DNA could stratify cancer risk in symptomatic patients. We aimed to evaluate the performance of a methylation-based multicancer early detection (MCED) diagnostic test in symptomatic patients referred from primary care. We did a multicentre, prospective, observational study at National Health Service (NHS) hospital sites in England and Wales. Participants aged 18 or older referred with non-specific symptoms or symptoms potentially due to gynaecological, lung, or upper or lower gastrointestinal cancers were included and gave a blood sample when they attended for urgent investigation. Participants were excluded if they had a history of or had received treatment for an invasive or haematological malignancy diagnosed within the preceding 3 years, were taking cytotoxic or demethylating agents that might interfere with the test, or had participated in another study of a GRAIL MCED test. Patients were followed until diagnostic resolution or up to 9 months. Cell-free DNA was isolated and the MCED test performed blinded to the clinical outcome. MCED predictions were compared with the diagnosis obtained by standard care to establish the primary outcomes of overall positive and negative predictive value, sensitivity, and specificity. Outcomes were assessed in participants with a valid MCED test result and diagnostic resolution. SYMPLIFY is registered with ISRCTN (ISRCTN10226380) and has completed follow-up at all sites. 6238 participants were recruited between July 7 and Nov 30, 2021, across 44 hospital sites. 387 were excluded due to staff being unable to draw blood, sample errors, participant withdrawal, or identification of ineligibility after enrolment. Of 5851 clinically evaluable participants, 376 had no MCED test result and 14 had no information as to final diagnosis, resulting in 5461 included in the final cohort for analysis with an evaluable MCED test result and diagnostic outcome (368 [6·7%] with a cancer diagnosis and 5093 [93·3%] without a cancer diagnosis). The median age of participants was 61·9 years (IQR 53·4–73·0), 3609 (66·1%) were female and 1852 (33·9%) were male. The MCED test detected a cancer signal in 323 cases, in whom 244 cancer was diagnosed, yielding a positive predictive value of 75·5% (95% CI 70·5–80·1), negative predictive value of 97·6% (97·1–98·0), sensitivity of 66·3% (61·2–71·1), and specificity of 98·4% (98·1–98·8). Sensitivity increased with increasing age and cancer stage, from 24·2% (95% CI 16·0–34·1) in stage I to 95·3% (88·5–98·7) in stage IV. For cases in which a cancer signal was detected among patients with cancer, the MCED test's prediction of the site of origin was accurate in 84·8% (95% CI 79·5–89·0) of cases. Sensitivity 80·4% (95% CI 66·1–90·6) and negative predictive value 99·1% (98·2–99·6) were highest for patients with symptoms mandating investigation for upper gastrointestinal cancer. This first large-scale prospective evaluation of an MCED diagnostic test in a symptomatic population demonstrates the feasibility of using an MCED test to assist clinicians with decisions regarding urgency and route of referral from primary care. Our data provide the basis for a prospective, interventional study in patients presenting to primary care with non-specific signs and symptoms. GRAIL Bio UK.

Road maintenance and cleaning in winter are performed with ploughshares. Due to the fact that the layer of snow and ice that is removed from the road surface contains various hard impurities, ploughshares are exposed to high intensity abrasive wear. This article deals with the resistance to abrasive wear of originally used ploughshare materials and the materials that were designed as a suitable modification of the ploughshare to increase its service life. The chemical composition of materials used to manufacture ploughshare components is unknown. For this reason, they were analyzed with an ARL 4460 spectrometer, which was used to analyze the element content. The main part of the research was focused on the abrasion resistance test, which was performed according to the GOST 23.208-79 standard. Based on the chemical analysis, it was found that the basic body of the ploughshare was made of S355J2G3 steel, and the raking blade material was made of 37MnSi5 steel. The original material (steel S355J2G3) of the ploughshare body as a reference standard was compared to steel HARDOX 450. Furthermore, a sample made of the original material of the raking blade (steel 37MnSi5) was used as a reference standard, the properties of which were compared to the newly designed OK 84.58 and UTP 690 hardfacing materials. The parametric test method of statistical hypotheses was also used to process and evaluate the weight losses of the selected materials.

To ensure the care of forests, it is necessary to make them sufficiently accessible by forest roads. The basic working tool are hammers, or round shanks of various shapes, composed of a body and a tip. They are subject to a strong abrasive environment, which often leads to damage up to the complete destruction of the functional part of the tool. For these reasons, it is necessary to deal with the possibilities for increasing their lifetime. One of the possibilities of increasing the service life of these tools is hardfacing by welding. The article deals with the abrasive resistance of the original material of the tool and the hardfacing materials. Based on the chemical analysis of the base material of the tool, we found that the tool is made of manganese steel 38Mn6. This material was used as a standard and was compared with the hardfacing materials Abradur 58, E DUR 600, UTP DUR 600 and OK 84.58. Electron microscopy was used to evaluate the microstructure. Next, the Rockwell hardness measurement was performed on the samples. The original tool material 38Mn6 reached the lowest hardness value, namely, 21 HRC. The highest value was reached by the hardfacing material E DUR 600, namely, 59 HRC. Subsequently, a test of resistance to abrasive wear was performed according to GOST 23.208-79. Based on this test, we can conclude that the highest value of resistance to abrasive wear was achieved by Abradur 58. Even though the hardness of this coating was slightly lower than the hardfacing material E DUR 600, specifically 56 HRC, we can state that this hardfacing material (Abradur 58) achieved the best results among the investigated materials.

This article focuses on the possibilities of increasing the service life of tools for crushing unwanted growths. One way to increase their service life is to increase the hardness and resistance to abrasive wear of exposed surfaces of the tool, which are their face and back. At the same time, however, care must be taken to ensure that the shape and weight of the tool is not altered after the additive has been hardfaced on. Thus, the tool was first modified by removing the material by milling from the face and back. Subsequently, two surfacing materials, namely UTP 690 and OK WearTrode 55, were chosen and hardfaced by welding onto the pre-prepared surfaces. After hardfacing by welding, the tools were ground to their original shape and their weight was measured. Subsequently, the tool was sawn, and specimens were created for Rockwell hardness evaluation, material microstructure and for abrasive wear resistance testing as per ASTM G133-95. The OK WearTrode 55 electrode is a hardfacing electrode that produces weld metal with a high-volume fraction of fine carbides in a martensitic matrix. Better results were achieved by the UTP 690 hardfacing material. The hardness was 3.1 times higher compared to the base tool material 16MnCr5 and 1.2 times higher than the OK WearTrode 55 material. The abrasive wear resistance was 2.76 times higher compared to 16MnCr5, and 1.14 times higher compared to the OK WearTrode 55 material. The choice of a suitable pre-treatment for the tool and the selection and application of such additional material, which with its complex properties better resists the effects of the working environment, is a prerequisite for increasing the service life of tools working in forestry.

The aim of this work was to assess the suitability of selected methods of surface treatment on X48CrMoV8-1-1 tool steel for application on chipping knives in wood-chipping machines. Three material surface conditions of X48CrMoV8-1-1 tool steel were evaluated for their tribological scratching behavior. The first surface condition was related to the conventionally machined chipping knife from the manufacturer without surface treatment. The second condition involved plasma nitriding treatment, and the third was a PVD-coated surface with “CROSAL ® Plus” (AlCrN based) coating. Several complementary analyses were carried out, namely microstructural observations, nano-indentation measurements, and tribological scratch tests. From the scratch tests, friction coefficients depending on applied load were determined. The best nano-indentation results were obtained for the PVD-coated surface, namely 23.7 ± 1.6 GPa for nanohardness and 270.3 ± 19.0 GPa for elasticity modulus. The best results of tribological and scratching behavior were obtained for the plasma-nitrided surface, namely 0.34 ± 0.21 for coefficient of friction and 1.88 × 10-6 mm3/N.m for specific wear rate. Based on the obtained results of laboratory tests, it can be concluded that the plasma-nitrided surface of X48CrMoV8-1-1 tool steel can ensure its better tribological performance compared to other investigated material conditions.

Infections acquired in hospital are an important cause of morbidity and mortality in very preterm infants. Several small trials have suggested that supplementing the enteral diet of very preterm infants with lactoferrin, an antimicrobial protein processed from cow's milk, prevents infections and associated complications. The aim of this large randomised controlled trial was to collect data to enhance the validity and applicability of the evidence from previous trials to inform practice. In this randomised placebo-controlled trial, we recruited very preterm infants born before 32 weeks' gestation in 37 UK hospitals and younger than 72 h at randomisation. Exclusion criteria were presence of a severe congenital anomaly, anticipated enteral fasting for longer than 14 days, or no realistic prospect of survival. Eligible infants were randomly assigned (1:1) to receive either enteral bovine lactoferrin (150 mg/kg per day; maximum 300 mg/day; lactoferrin group) or sucrose (same dose; control group) once daily until 34 weeks' postmenstrual age. Web-based randomisation minimised for recruitment site, gestation (completed weeks), sex, and single versus multifetal pregnancy. Parents, caregivers, and outcome assessors were unaware of group assignment. The primary outcome was microbiologically confirmed or clinically suspected late-onset infection (occurring >72 h after birth), which was assessed in all participants for whom primary outcome data was available by calculating the relative risk ratio with 95% CI between the two groups. The trial is registered with the International Standard Randomised Controlled Trial Number 88261002. We recruited 2203 participants between May 7, 2014, and Sept 28, 2017, of whom 1099 were assigned to the lactoferrin group and 1104 to the control group. Four infants had consent withdrawn or unconfirmed, leaving 1098 infants in the lactoferrin group and 1101 in the sucrose group. Primary outcome data for 2182 infants (1093 [99·5%] of 1098 in the lactoferrin group and 1089 [99·0] of 1101 in the control group) were available for inclusion in the modified intention-to-treat analyses. 316 (29%) of 1093 infants in the intervention group acquired a late-onset infection versus 334 (31%) of 1089 in the control group. The risk ratio adjusted for minimisation factors was 0·95 (95% CI 0·86–1·04; p=0·233). During the trial there were 16 serious adverse events for infants in the lactoferrin group and 10 for infants in the control group. Two events in the lactoferrin group (one case of blood in stool and one death after intestinal perforation) were assessed as being possibly related to the trial intervention. Enteral supplementation with bovine lactoferrin does not reduce the risk of late-onset infection in very preterm infants. These data do not support its routine use to prevent late-onset infection and associated morbidity or mortality in very preterm infants. UK National Institute for Health Research Health Technology Assessment programme (10/57/49).

Staphylococcus are common bacteria that can be a component of the natural microbiota of the body of human and animal hosts or cause serious infections. The aim of this study was to analyze the presence of S. aureus in samples from two sheep breeds (Świniarka and Uhruska), assess the antimicrobial susceptibility and virulence profile of these microorganisms, and perform molecular comparative analysis of these bacteria. One hundred and three isolates of S. aureus strains were obtained (including five MRSA strains) and the highest phenotypic resistance to tetracycline (46.6%), clindamycin (45.6%), erythromycin (39.8%), and penicillin (31.1%) was confirmed. The tetL gene (27.2%) and the seB gene (44.7%) were the most frequently detected in strains. Three new sequence types in the MRSA isolates (ST 9313, ST 9314, ST 9315) were identified. In conclusion, our results confirm that sheep are significant reservoirs of S. aureus, especially MRSA strains, varying in terms of both resistance and virulence and with the potential to spread between individuals in the same herd, which may pose a potential health problem.

Hapln4 is a link protein which stabilizes the binding between lecticans and hyaluronan in perineuronal nets (PNNs) in specific brain regions, including the medial nucleus of the trapezoid body (MNTB). The aim of this study was: (1) to reveal possible age-related alterations in the extracellular matrix composition in the MNTB and inferior colliculus, which was devoid of Hapln4 and served as a negative control, (2) to determine the impact of the Hapln4 deletion on the values of the ECS diffusion parameters in young and aged animals and (3) to verify that PNNs moderate age-related changes in the ECS diffusion, and that Hapln4-brevican complex is indispensable for the correct protective function of the PNNs. To achieve this, we evaluated the ECS diffusion parameters using the real-time iontophoretic method in the selected region in young adult (3 to 6-months-old) and aged (12 to 18-months-old) wild type and Hapln4 knock-out (KO) mice. The results were correlated with an immunohistochemical analysis of the ECM composition and astrocyte morphology. We report that the ECM composition is altered in the aged MNTB and aging is a critical point, revealing the effect of Hapln4 deficiency on the ECS diffusion. All of our findings support the hypothesis that the ECM changes in the MNTB of aged KO animals affect the ECS parameters indirectly, via morphological changes of astrocytes, which are in direct contact with synapses and can be influenced by the ongoing synaptic transmission altered by shifts in the ECM composition.

Astrocytes are crucial for the functioning of the nervous system as they maintain the ion homeostasis via volume regulation. Pathological states, such as amyotrophic lateral sclerosis (ALS), affect astrocytes and might even cause a loss of such functions. In this study, we examined astrocytic swelling/volume recovery in both the brain and spinal cord of the SOD1 animal model to determine the level of their impairment caused by the ALS-like pathology. Astrocyte volume changes were measured in acute brain or spinal cord slices during and after exposure to hyperkalemia. We then compared the results with alterations of extracellular space (ECS) diffusion parameters, morphological changes, expression of the Kir4.1 channel and the potassium concentration measured in the cerebrospinal fluid, to further disclose the link between potassium and astrocytes in the ALS-like pathology. Morphological analysis revealed astrogliosis in both the motor cortex and the ventral horns of the SOD1 spinal cord. The activated morphology of SOD1 spinal astrocytes was associated with the results from volume measurements, which showed decreased swelling of these cells during hyperkalemia. Furthermore, we observed lower shrinkage of ECS in the SOD1 spinal ventral horns. Immunohistochemical analysis then confirmed decreased expression of the Kir4.1 channel in the SOD1 spinal cord, which corresponded with the diminished volume regulation. Despite astrogliosis, cortical astrocytes in SOD1 mice did not show alterations in swelling nor changes in Kir4.1 expression, and we did not identify significant changes in ECS parameters. Moreover, the potassium level in the cerebrospinal fluid did not deviate from the physiological concentration. The results we obtained thus suggest that ALS-like pathology causes impaired potassium uptake associated with Kir4.1 downregulation in the spinal astrocytes, but based on our data from the cortex, the functional impairment seems to be independent of the morphological state.

All the metabolic and physiological functions of the body have a circadian rhythm, regulated by the day and night cycle of the environment. The homeostatic physiology of the circadian rhythm processes the regulation of sleep and the sleep/wake cycle. Circadian rhythm is the 24-hour rhythm of an internal clock existing in the brain, responsible for regulation of cycles of alertness and sleepiness by responding to the alternation of light and darkness in the environment. The Earth's rotation around its axis synchronizes circadian rhythms in physiology and behavior. The circadian system has evolved to help the adaptation of our physiological functions to changes in the environment and anticipate changes in radiation, temperature, and food intake. Homo sapiens would not be able to optimize energy expenditure and the internal physiology of the body without this endogenous circadian clock. This communication aims to highlight the role of circadian function in cardiovascular and metabolic diseases.